Literature DB >> 15644180

Viral delivery of recombinant short hairpin RNAs.

Beverly L Davidson1, Scott Q Harper.   

Abstract

Recent work demonstrates that RNA interference (RNAi) can coordinate protein expression. Inhibitory RNAs are expressed naturally in cells as microRNAs (miRNAs) or introduced into cells as small interfering RNAs (siRNAs). Both types of small RNAs can be used at the bench to silence mRNA expression. For many researchers, transfection of siRNAs synthesized in vitro or purchased from commercial sources is impractical for the cellular system under study. As an alternative to transfection-based methods, we provide a practical approach to accomplish siRNA-mediated gene silencing through the generation and introduction of recombinant viral vectors expressing short hairpin RNAs (shRNAs). shRNAs are subsequently processed to siRNAs in vivo, leading to efficient, and, in some cases, long-term silencing.

Mesh:

Substances:

Year:  2005        PMID: 15644180     DOI: 10.1016/S0076-6879(04)92009-5

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  14 in total

1.  A novel tumor suppressor miRNA miR-520e contributes to suppression of hepatoma.

Authors:  Bo-an Li
Journal:  Acta Pharmacol Sin       Date:  2012-01       Impact factor: 6.150

Review 2.  Experimental surgical therapies for Huntington's disease.

Authors:  Jelle Demeestere; Wim Vandenberghe
Journal:  CNS Neurosci Ther       Date:  2010-12-28       Impact factor: 5.243

Review 3.  Strategies to Modulate MicroRNA Functions for the Treatment of Cancer or Organ Injury.

Authors:  Tae Jin Lee; Xiaoyi Yuan; Keith Kerr; Ji Young Yoo; Dong H Kim; Balveen Kaur; Holger K Eltzschig
Journal:  Pharmacol Rev       Date:  2020-07       Impact factor: 25.468

Review 4.  RNAi medicine for the brain: progresses and challenges.

Authors:  Ryan L Boudreau; Edgardo Rodríguez-Lebrón; Beverly L Davidson
Journal:  Hum Mol Genet       Date:  2011-03-31       Impact factor: 6.150

5.  Tet-Mediated DNA Demethylation Is Required for SWI/SNF-Dependent Chromatin Remodeling and Histone-Modifying Activities That Trigger Expression of the Sp7 Osteoblast Master Gene during Mesenchymal Lineage Commitment.

Authors:  Hugo Sepulveda; Alejandro Villagra; Martin Montecino
Journal:  Mol Cell Biol       Date:  2017-09-26       Impact factor: 4.272

6.  miRNA-mediated immune regulation and immunotherapeutic potential in glioblastoma.

Authors:  Krishan Jethwa; Jun Wei; Kayla McEnery; Amy B Heimberger
Journal:  Clin Investig (Lond)       Date:  2011-12

7.  Therapeutic impact of systemic AAV-mediated RNA interference in a mouse model of myotonic dystrophy.

Authors:  Darren R Bisset; Ewa A Stepniak-Konieczna; Maja Zavaljevski; Jessica Wei; Gregory T Carter; Michael D Weiss; Joel R Chamberlain
Journal:  Hum Mol Genet       Date:  2015-06-16       Impact factor: 6.150

8.  Putative tumor suppressor cytoglobin promotes aryl hydrocarbon receptor ligand-mediated triple negative breast cancer cell death.

Authors:  Leah K Rowland; Petreena S Campbell; Nicole Mavingire; Jonathan V Wooten; Lancelot McLean; Dain Zylstra; Gabriell Thorne; Devin Daly; Kristopher Boyle; Sonya Whang; Juli Unternaehrer; Eileen J Brantley
Journal:  J Cell Biochem       Date:  2018-11-18       Impact factor: 4.429

9.  RNAi reduces expression and intracellular retention of mutant cartilage oligomeric matrix protein.

Authors:  Karen L Posey; Peiman Liu; Huiqiu R Wang; Alka C Veerisetty; Joseph L Alcorn; Jacqueline T Hecht
Journal:  PLoS One       Date:  2010-04-22       Impact factor: 3.240

Review 10.  RNAi-based gene therapy for dominant Limb Girdle Muscular Dystrophies.

Authors:  Jian Liu; Scott Q Harper
Journal:  Curr Gene Ther       Date:  2012-08       Impact factor: 4.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.